Proprietary Name,NDC Package Code,Strength,Dosage Form,Route,Appl. No.,Labeler Name,Product NDC,Nonproprietary Name,Substance Name,Product Type Name,Start Marketing Date,End Marketing Date,Market Category,Package Description,Pharm Class,DEA,Sample Package,Listing Record Certified Through: E.E.S,24338-100-03,400 mg/1,TABLET,ORAL,ANDA061905,"Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)",24338-100,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,06/28/2021,N/A,ANDA,30 TABLET in 1 BOTTLE (24338-100-03),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 E.E.S,24338-134-02,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,NDA050207,"Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)",24338-134,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,NDA,100 mL in 1 BOTTLE (24338-134-02),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 E.E.S,24338-136-10,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,NDA050207,"Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)",24338-136,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,NDA,200 mL in 1 BOTTLE (24338-136-10),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Ery-Ped,24338-130-13,400 mg/5mL,SUSPENSION,ORAL,NDA050207,"Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)",24338-130,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,06/14/2012,N/A,NDA,100 mL in 1 BOTTLE (24338-130-13),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Ery-Ped,24338-132-13,200 mg/5mL,SUSPENSION,ORAL,NDA050207,"Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)",24338-132,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,07/05/2011,N/A,NDA,100 mL in 1 BOTTLE (24338-132-13),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-217-40,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-217,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,12/21/2011,N/A,ANDA,"40 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-40)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-525-21,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-525,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/01/2011,N/A,ANDA,"21 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-525-21)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-525-40,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-525,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/01/2011,N/A,ANDA,"40 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-525-40)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-525-42,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-525,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/01/2011,N/A,ANDA,"42 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-525-42)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,43063-569-30,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",43063-569,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,04/14/2015,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (43063-569-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-525-63,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-525,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/01/2011,N/A,ANDA,"63 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-525-63)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-217-28,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-217,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,12/21/2011,N/A,ANDA,"28 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-28)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,24338-122-03,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"Arbor Pharmaceuticals, Inc.",24338-122,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,11/17/2017,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,24338-122-13,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"Arbor Pharmaceuticals, Inc.",24338-122,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,24338-124-03,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"Arbor Pharmaceuticals, Inc.",24338-124,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,11/17/2017,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-124-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,24338-124-13,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"Arbor Pharmaceuticals, Inc.",24338-124,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-124-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,24338-126-03,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"Arbor Pharmaceuticals, Inc.",24338-126,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,11/17/2017,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-126-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,24338-126-13,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"Arbor Pharmaceuticals, Inc.",24338-126,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,04/18/2011,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-126-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERY-TAB,55289-525-30,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,"PD-Rx Pharmaceuticals, Inc.",55289-525,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/01/2011,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-525-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-01,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-15,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-15)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,24338-106-03,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"Arbor Pharmaceuticals, Inc.",24338-106,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,08/31/2019,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (24338-106-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-56,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-56)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-04,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-04)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-20,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-20)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-10,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-10)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-28,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-28)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-40,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-40)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,55289-112-98,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"PD-Rx Pharmaceuticals, Inc.",55289-112,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,"120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-112-98)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythrocin Stearate,24338-106-20,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA060359,"Arbor Pharmaceuticals, Inc.",24338-106,ERYTHROMYCIN STEARATE,ERYTHROMYCIN STEARATE,HUMAN PRESCRIPTION DRUG,08/01/2011,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (24338-106-20)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,72241-036-05,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Modavar Pharmaceuticals LLC,72241-036,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/31/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (72241-036-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,72241-036-22,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Modavar Pharmaceuticals LLC,72241-036,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/31/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (72241-036-22)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,72241-037-05,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Modavar Pharmaceuticals LLC,72241-037,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/31/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (72241-037-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,72241-037-22,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Modavar Pharmaceuticals LLC,72241-037,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/31/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (72241-037-22)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,13668-586-30,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA211975,Torrent Pharmaceuticals Limited,13668-586,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,09/21/2021,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-586-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,13668-588-30,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA211975,Torrent Pharmaceuticals Limited,13668-588,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,09/21/2021,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-588-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1485-1,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA209720,Amneal Pharmaceuticals NY LLC,69238-1485,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/11/2018,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (69238-1485-1)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-105-03,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,Wilshire Pharmaceuticals,52536-105,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/15/2018,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (52536-105-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-105-13,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,Wilshire Pharmaceuticals,52536-105,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/15/2018,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (52536-105-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,13668-606-30,250 mg/1,"TABLET, COATED",ORAL,ANDA212015,Torrent Pharmaceuticals Limited,13668-606,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,04/12/2022,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (13668-606-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,13668-607-30,500 mg/1,"TABLET, COATED",ORAL,ANDA212015,Torrent Pharmaceuticals Limited,13668-607,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,04/12/2022,N/A,ANDA,"30 TABLET, COATED in 1 BOTTLE (13668-607-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,13668-606-01,250 mg/1,"TABLET, COATED",ORAL,ANDA212015,Torrent Pharmaceuticals Limited,13668-606,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/06/2020,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (13668-606-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,13668-606-05,250 mg/1,"TABLET, COATED",ORAL,ANDA212015,Torrent Pharmaceuticals Limited,13668-606,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/07/2020,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (13668-606-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,13668-607-01,500 mg/1,"TABLET, COATED",ORAL,ANDA212015,Torrent Pharmaceuticals Limited,13668-607,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/06/2020,N/A,ANDA,"100 TABLET, COATED in 1 BOTTLE (13668-607-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,13668-607-05,500 mg/1,"TABLET, COATED",ORAL,ANDA212015,Torrent Pharmaceuticals Limited,13668-607,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/07/2020,N/A,ANDA,"500 TABLET, COATED in 1 BOTTLE (13668-607-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1484-1,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA209720,Amneal Pharmaceuticals NY LLC,69238-1484,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/11/2018,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (69238-1484-1)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-103-13,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,Wilshire Pharmaceuticals,52536-103,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/15/2018,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (52536-103-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-103-03,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,Wilshire Pharmaceuticals,52536-103,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/15/2018,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (52536-103-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,0093-5571-01,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA214549,"Teva Pharmaceuticals USA, Inc.",0093-5571,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (0093-5571-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,0093-5571-56,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA214549,"Teva Pharmaceuticals USA, Inc.",0093-5571,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (0093-5571-56)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,0093-5572-01,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA214549,"Teva Pharmaceuticals USA, Inc.",0093-5572,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (0093-5572-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,0093-5572-56,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA214549,"Teva Pharmaceuticals USA, Inc.",0093-5572,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (0093-5572-56)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-180-03,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,Wilshire Pharmaceuticals,52536-180,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-180-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-180-10,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,Wilshire Pharmaceuticals,52536-180,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-180-10)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-183-03,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,Wilshire Pharmaceuticals,52536-183,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-183-10,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,Wilshire Pharmaceuticals,52536-183,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-183-10)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-186-03,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,Wilshire Pharmaceuticals,52536-186,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-186-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,52536-186-10,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA062298,Wilshire Pharmaceuticals,52536-186,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/22/2019,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (52536-186-10)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-025-40,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-025,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2012,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-025-40)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,50090-5918-6,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA214549,A-S Medication Solutions,50090-5918,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,06/09/2022,N/A,ANDA,"90 TABLET, FILM COATED in 1 BOTTLE (50090-5918-6)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,50090-5918-5,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA214549,A-S Medication Solutions,50090-5918,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,02/14/2022,N/A,ANDA,"3 TABLET, FILM COATED in 1 BOTTLE (50090-5918-5)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1471-3,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA210954,Amneal Pharmaceuticals NY LLC,69238-1471,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,08/27/2021,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1471-3)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1472-3,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA210954,Amneal Pharmaceuticals NY LLC,69238-1472,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,08/27/2021,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1472-3)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1473-3,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA210954,Amneal Pharmaceuticals NY LLC,69238-1473,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,08/27/2021,N/A,ANDA,"30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1473-3)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,71209-100-01,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Cadila Pharmaceuticals Limited,71209-100,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71209-100-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,71209-100-05,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Cadila Pharmaceuticals Limited,71209-100,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (71209-100-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,71209-101-01,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Cadila Pharmaceuticals Limited,71209-101,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (71209-101-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,71209-101-05,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Cadila Pharmaceuticals Limited,71209-101,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/06/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (71209-101-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-025-04,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-025,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2012,N/A,ANDA,"4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-025-04)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-762-01,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-762,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (67877-762-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-762-05,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-762,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (67877-762-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-762-30,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-762,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (67877-762-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-762-33,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-762,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"1 BLISTER PACK in 1 CARTON (67877-762-33) / 10 TABLET, FILM COATED in 1 BLISTER PACK","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-763-01,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-763,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (67877-763-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-763-05,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-763,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"500 TABLET, FILM COATED in 1 BOTTLE (67877-763-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-763-30,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-763,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (67877-763-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,67877-763-33,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA216066,"Ascend Laboratories, LLC",67877-763,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/14/2022,N/A,ANDA,"1 BLISTER PACK in 1 CARTON (67877-763-33) / 10 TABLET, FILM COATED in 1 BLISTER PACK","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,75834-242-01,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,"Nivagen Pharmaceuticals, Inc.",75834-242,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/15/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (75834-242-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,75834-242-30,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,"Nivagen Pharmaceuticals, Inc.",75834-242,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/15/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (75834-242-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,75834-243-01,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,"Nivagen Pharmaceuticals, Inc.",75834-243,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/15/2021,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (75834-243-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,75834-243-30,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,"Nivagen Pharmaceuticals, Inc.",75834-243,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/15/2021,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (75834-243-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,73082-010-01,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Orange Pharmaceuticals USA LLC,73082-010,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/05/2019,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (73082-010-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,73082-010-30,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Orange Pharmaceuticals USA LLC,73082-010,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/05/2019,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (73082-010-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,73082-020-01,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Orange Pharmaceuticals USA LLC,73082-020,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/05/2019,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (73082-020-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,73082-020-30,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA213628,Orange Pharmaceuticals USA LLC,73082-020,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,10/05/2019,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (73082-020-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1471-1,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA210954,Amneal Pharmaceuticals NY LLC,69238-1471,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/07/2019,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1471-1)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1472-1,333 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA210954,Amneal Pharmaceuticals NY LLC,69238-1472,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/07/2019,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1472-1)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1473-1,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA210954,Amneal Pharmaceuticals NY LLC,69238-1473,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/07/2019,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1473-1)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1484-3,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA209720,Amneal Pharmaceuticals NY LLC,69238-1484,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/11/2018,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (69238-1484-3)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,69238-1485-3,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA209720,Amneal Pharmaceuticals NY LLC,69238-1485,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,03/11/2018,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (69238-1485-3)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-025-28,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-025,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2012,N/A,ANDA,"28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-025-28)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-025-20,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-025,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2012,N/A,ANDA,"20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-025-20)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-025-30,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-025,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,05/04/2012,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-025-30)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-075-03,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-075,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,12/18/2013,N/A,ANDA,"3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,55289-075-40,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"PD-Rx Pharmaceuticals, Inc.",55289-075,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,12/18/2013,N/A,ANDA,"40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-40)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,24338-102-03,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"Arbor Pharmaceuticals, Inc.",24338-102,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,11/20/2017,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (24338-102-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,24338-102-13,250 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"Arbor Pharmaceuticals, Inc.",24338-102,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,09/06/2011,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (24338-102-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,24338-104-03,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"Arbor Pharmaceuticals, Inc.",24338-104,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,11/20/2017,N/A,ANDA,"30 TABLET, FILM COATED in 1 BOTTLE (24338-104-03)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin,24338-104-13,500 mg/1,"TABLET, FILM COATED",ORAL,ANDA061621,"Arbor Pharmaceuticals, Inc.",24338-104,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,09/06/2011,N/A,ANDA,"100 TABLET, FILM COATED in 1 BOTTLE (24338-104-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,24338-120-13,250 mg/1,"CAPSULE, DELAYED RELEASE",ORAL,ANDA062746,"Arbor Pharmaceuticals, Inc.",24338-120,Erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,01/10/2012,N/A,ANDA,"100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24338-120-13)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,13668-586-01,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA211975,Torrent Pharmaceuticals Limited,13668-586,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/26/2021,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-586-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,13668-586-05,250 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA211975,Torrent Pharmaceuticals Limited,13668-586,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/26/2021,N/A,ANDA,"500 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-586-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,13668-588-01,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA211975,Torrent Pharmaceuticals Limited,13668-588,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/26/2021,N/A,ANDA,"100 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-588-01)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN,13668-588-05,500 mg/1,"TABLET, DELAYED RELEASE",ORAL,ANDA211975,Torrent Pharmaceuticals Limited,13668-588,ERYTHROMYCIN,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/26/2021,N/A,ANDA,"500 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-588-05)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 erythromycin,68308-250-10,250 mg/1,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,NDA050536,Mayne Pharma Inc.,68308-250,erythromycin,ERYTHROMYCIN,HUMAN PRESCRIPTION DRUG,07/29/2013,N/A,NDA AUTHORIZED GENERIC,"100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (68308-250-10)","Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN ETHYLSUCCINATE,24338-110-03,400 mg/1,TABLET,ORAL,ANDA061904,"Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)",24338-110,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,10/03/2011,N/A,ANDA,30 TABLET in 1 BOTTLE (24338-110-03),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,52536-136-13,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,NDA050207,Wilshire Pharmaceuticals Inc.,52536-136,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,09/28/2016,N/A,NDA,200 mL in 1 BOTTLE (52536-136-13),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,62559-440-01,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,ANDA062055,"ANI Pharmaceuticals, Inc.",62559-440,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,09/27/2016,11/30/2023,ANDA,100 mL in 1 BOTTLE (62559-440-01),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,52536-134-13,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,NDA050207,Wilshire Pharmaceuticals Inc.,52536-134,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,09/28/2016,N/A,NDA,100 mL in 1 BOTTLE (52536-134-13),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,75834-294-01,400 mg/5mL,SUSPENSION,ORAL,ANDA216212,"Nivagen Pharmaceuticals, Inc.",75834-294,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,ANDA,100 mL in 1 BOTTLE (75834-294-01),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2024 Erythromycin Ethylsuccinate,75834-295-01,200 mg/5mL,SUSPENSION,ORAL,ANDA216212,"Nivagen Pharmaceuticals, Inc.",75834-295,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,02/01/2023,N/A,ANDA,100 mL in 1 BOTTLE (75834-295-01),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2024 ERYTHROMYCIN ETHYLSUCCINATE,52536-130-13,400 mg/5mL,SUSPENSION,ORAL,NDA050207,Wilshire Pharmaceuticals,52536-130,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,03/25/2019,N/A,NDA,100 mL in 1 BOTTLE (52536-130-13),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 ERYTHROMYCIN ETHYLSUCCINATE,52536-132-13,200 mg/5mL,SUSPENSION,ORAL,NDA050207,Wilshire Pharmaceuticals,52536-132,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,08/24/2020,N/A,NDA,100 mL in 1 BOTTLE (52536-132-13),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,62559-630-01,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,ANDA062055,"ANI Pharmaceuticals, Inc.",62559-630,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,03/25/2019,N/A,ANDA,100 mL in 1 BOTTLE (62559-630-01),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,62559-631-01,400 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,ANDA062055,"ANI Pharmaceuticals, Inc.",62559-631,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,03/25/2019,N/A,ANDA,100 mL in 1 BOTTLE (62559-631-01),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,62559-440-02,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,ANDA062055,"ANI Pharmaceuticals, Inc.",62559-440,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,09/27/2016,N/A,ANDA,200 mL in 1 BOTTLE (62559-440-02),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin ethylsuccinate,71209-102-21,200 mg/5mL,FOR SUSPENSION,ORAL,ANDA216212,Cadila Pharmaceuticals Limited,71209-102,Erythromycin ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,11/21/2022,N/A,ANDA,100 mL in 1 BOTTLE (71209-102-21),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin ethylsuccinate,71209-103-21,400 mg/5mL,FOR SUSPENSION,ORAL,ANDA216212,Cadila Pharmaceuticals Limited,71209-103,Erythromycin ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,11/21/2022,N/A,ANDA,100 mL in 1 BOTTLE (71209-103-21),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,69238-1503-1,200 mg/5mL,SUSPENSION,ORAL,ANDA211204,Amneal Pharmaceuticals NY LLC,69238-1503,Erythromycin,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,11/04/2019,N/A,ANDA,100 mL in 1 BOTTLE (69238-1503-1),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,69238-1504-2,400 mg/5mL,SUSPENSION,ORAL,ANDA211204,Amneal Pharmaceuticals NY LLC,69238-1504,Erythromycin,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,11/04/2019,N/A,ANDA,100 mL in 1 BOTTLE (69238-1504-2),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023 Erythromycin Ethylsuccinate,63629-2500-1,200 mg/5mL,"GRANULE, FOR SUSPENSION",ORAL,NDA050207,Bryant Ranch Prepack,63629-2500,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,HUMAN PRESCRIPTION DRUG,05/24/2021,N/A,NDA,200 mL in 1 BOTTLE (63629-2500-1),"Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]",N/A,No,12/31/2023